cs.CVOct 19, 2026

Scaling Vision Foundation Models for Toxicologic Pathology

Authors: Jessica Loo, Theodoros Pissas, Byunghak Kang, Vincent A. Ella, Xiaoyan Zhang, Kevin Sweeney, Walter Georgescu, Prateek Katiyar, 

Organizations: Novartis Institutes for Biomedical Research Inc., Cambridge, MA, USA · Novartis Pharma AG, Basel, Switzerland · Novartis Ireland Limited, Dublin, Ireland

Abstract

Here, we present TOX-FM, a family of non-clinical PFMs trained on large-scale diverse histopathology datasets of over one million whole slide images consisting of over 60 organs across six animal species from over 14,000 toxicology studies across six decades. We introduce a comprehensive benchmark of 18 non-clinical downstream tasks, incorporate an established benchmark of 9 clinical downstream tasks, and evaluate TOX-FM against state-of-the-art clinical PFMs across both non-clinical and clinical domains. Notably, we explore open questions surrounding domain-specific training and cross-domain generalization, offering insights into the opportunities and challenges of applying PFMs in the non-clinical domain.

Figures & tables

Appendix figures & tables11 assets

Supplementary material from the paper’s appendix.

Appendix

Explore similar work

May 25, 2026

Benchmarking Pathology Foundation Models for Spatial Domain Understanding

Pathology foundation models (PFMs) have emerged as a core approach for learning transferable representations from whole slide images (WSIs), and they are typically benchmarked through downstream clinical endpoints. While such task level evaluations are indispensable, they offer limited insight into what the representations themselves encode, particularly whether PFM embeddings can distinguish meaningful tissue regions and capture their spatial relationships. We present SpaPath-Bench, a representation level benchmark designed to diagnose spatial representation capability in PFMs. SpaPath-Bench formulates spatial domain identification (SDI) on paired whole slide image and spatial transcriptomics (ST) data as a diagnostic task. It curates 42 public paired WSI and ST slides, enables large scale evaluation across 19 encoders and seven SDI methods, and measures partition quality using three complementary criteria: unsupervised spatial coherence, transcriptomics referenced agreement, and expert referenced agreement. Across 83K runs, SpaPath-Bench reveals that different pretraining paradigms capture distinct aspects of tissue spatial architecture, and it provides practical guidance for building the next generation of spatially aware computational pathology models. Code and data pipelines are publicly available at https://bokai-zhao.github.io/SpaPath-benchboard/.
Aug 26, 2026

VIPER: An Expert-Curated Benchmark for Vision-Language Models in Veterinary Pathology

Pathology vision-language models are advancing rapidly, yet existing benchmarks remain focused on human tissue, particularly oncology, leaving non-human pathology largely unaddressed. This gap is especially important in toxicologic pathology, where microscopic tissue examination of laboratory animals is a core component of preclinical drug safety assessment. To address it, we introduce VIPER, the first expert-curated benchmark for vision-language model evaluation in toxicologic pathology. VIPER contains 1,251 questions associated with 419 H&E-stained rat histology images across seven organ systems, covering multiple-choice, KPrim, and free-text formats. All questions were curated and validated by board-certified veterinary pathologists. In total, we benchmarked 16 models, including two newly introduced veterinary-pathology models, seven human pathology-specialized models, and seven general-purpose frontier models. The results identify a substantial domain gap between veterinary and human pathology, expose the risk of over-diagnosis of normal tissue in frontier models, and show that domain-specific training remains critical for visually grounded predictions. VIPER data and evaluation code are available at https://github.com/mahmoodlab/viper.
May 24, 2026

Discrepancy Minimization Improves Cross-Hospital Robustness in Digital Pathology

Pathology foundation models (PFMs) have advanced rapidly in recent years and support training classifiers for a range of histopathology tasks. However, their robustness across hospitals remains limited: performance often degrades when training a classifier on data from one hospital and evaluating it on another target hospital. We address this challenge by fine-tuning PFMs with a local maximum mean discrepancy (LMMD) objective that applies to two settings: domain adaptation, where unlabeled target-hospital data is available, and domain generalization, where target-hospital data is unavailable at all. Experiments at both the patch- and slide-level show consistent improvements across multiple PFMs and tasks.